Active Ratio Test (ART) as a Novel Diagnostic for Ovarian Cancer.
Sung-Woog KangAdam RainczukMartin K OehlerThomas W JoblingMagdalena PlebanskiAndrew N StephensPublished in: Diagnostics (Basel, Switzerland) (2021)
Our data demonstrate that ART provides a useful method to accurately discriminate between patients with benign versus malignant EOC, and highlights their relevance to ovarian cancer diagnosis. This marker combination may also be applicable in broader screening applications, to identify or discriminate benign from malignant disease in asymptomatic women.